OTCPK:NVLP.F

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Executive Summary

Nova Leap Health Corp. provides home and home health care services. More Details


Snowflake Analysis

Adequate balance sheet and fair value.

Share Price & News

How has Nova Leap Health's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: NVLP.F has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

-6.8%

NVLP.F

-2.3%

US Healthcare

-0.8%

US Market


1 Year Return

n/a

NVLP.F

21.0%

US Healthcare

13.8%

US Market

Return vs Industry: Insufficient data to determine how NVLP.F performed against the US Healthcare industry.

Return vs Market: Insufficient data to determine how NVLP.F performed against the US Market.


Shareholder returns

NVLP.FIndustryMarket
7 Day-6.8%-2.3%-0.8%
30 Day-9.5%-4.3%-5.0%
90 Day0%1.8%10.1%
1 Yearn/a22.6%21.0%16.4%13.8%
3 Yearn/a23.9%18.5%36.9%27.8%
5 Yearn/a50.1%39.4%85.0%64.2%

Price Volatility Vs. Market

How volatile is Nova Leap Health's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Nova Leap Health undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: NVLP.F ($0.25) is trading below our estimate of fair value ($3.22)

Significantly Below Fair Value: NVLP.F is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: NVLP.F is unprofitable, so we can't compare its PE Ratio to the US Healthcare industry average.

PE vs Market: NVLP.F is unprofitable, so we can't compare its PE Ratio to the US market.


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate NVLP.F's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: NVLP.F is good value based on its PB Ratio (2.4x) compared to the US Healthcare industry average (2.8x).


Next Steps

Future Growth

How is Nova Leap Health forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

13.9%

Forecasted Healthcare industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Nova Leap Health has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

  • Examine whether Nova Leap Health is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
  • While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on theOTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Nova Leap Health's filings and announcementshere.
  • Explore growth companies in the Healthcare industry.

Past Performance

How has Nova Leap Health performed over the past 5 years?

-5.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: NVLP.F is currently unprofitable.

Growing Profit Margin: NVLP.F is currently unprofitable.


Past Earnings Growth Analysis

Earnings Trend: NVLP.F is unprofitable, and losses have increased over the past 5 years at a rate of 5.7% per year.

Accelerating Growth: Unable to compare NVLP.F's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: NVLP.F is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (31.1%).


Return on Equity

High ROE: NVLP.F has a negative Return on Equity (-10.61%), as it is currently unprofitable.


Next Steps

Financial Health

How is Nova Leap Health's financial position?


Financial Position Analysis

Short Term Liabilities: NVLP.F's short term assets ($4.5M) exceed its short term liabilities ($4.1M).

Long Term Liabilities: NVLP.F's short term assets ($4.5M) exceed its long term liabilities ($2.7M).


Debt to Equity History and Analysis

Debt Level: NVLP.F's debt to equity ratio (68.5%) is considered high.

Reducing Debt: Insufficient data to determine if NVLP.F's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable NVLP.F has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: NVLP.F is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 49.3% per year.


Next Steps

Dividend

What is Nova Leap Health current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate NVLP.F's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate NVLP.F's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if NVLP.F's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if NVLP.F's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of NVLP.F's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.8yrs

Average board tenure


CEO

Chris Dobbin (45 yo)

no data

Tenure

US$305,000

Compensation

Mr. Christopher Donald Dobbin, also known as Chris, CPA, CA, serves as the Chief Executive Officer and President of Nova Leap Health Corp. and served as its Chief Financial Officer until October 2016. Mr. ...


CEO Compensation Analysis

Compensation vs Market: Chris's total compensation ($USD175.35K) is below average for companies of similar size in the US market ($USD603.09K).

Compensation vs Earnings: Chris's compensation has been consistent with company performance over the past year.


Board Members

NamePositionTenureCompensationOwnership
Christopher Dobbin
CEO, President & Directorno dataUS$305.00k11.56%
$ 2.0m
Michael O'Keefe
Independent Director4.83yrsUS$23.00k2.57%
$ 452.5k
Dana Hatfield
Independent Chairman of the Boardno dataUS$36.00k4.26%
$ 748.8k
Wayne Myles
Independent Director3yrsUS$18.00k1.78%
$ 312.4k

4.8yrs

Average Tenure

45yo

Average Age

Experienced Board: NVLP.F's board of directors are considered experienced (4.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 7.4%.


Top Shareholders

Company Information

Nova Leap Health Corp.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Nova Leap Health Corp.
  • Ticker: NVLP.F
  • Exchange: OTCPK
  • Founded: 2015
  • Industry: Health Care Services
  • Sector: Healthcare
  • Market Cap: CA$23.595m
  • Listing Market Cap: CA$17.595m
  • Shares outstanding: 65.54m
  • Website: https://novaleaphealth.com

Location

  • Nova Leap Health Corp.
  • 7071 Bayers Road
  • Suite 5003
  • Halifax
  • Nova Scotia
  • B3L 2C2
  • Canada

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
NLHTSXV (TSX Venture Exchange)YesCommon SharesCACADApr 2016
NVLP.FOTCPK (Pink Sheets LLC)YesCommon SharesUSUSDApr 2016

Biography

Nova Leap Health Corp. provides home and home health care services. Its services include dementia care, companionship, personal and respite care, cooking and meal preparation, light housekeeping, transport ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/09/27 05:47
End of Day Share Price2020/09/25 00:00
Earnings2020/06/30
Annual Earnings2019/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.